Francis GIRAUD

Francis GIRAUD is a Lecturer at Blaise Pascal University in Clermont-Ferrand, France, specializing in Organic and Medicinal Chemistry. He is affiliated with the COM team (Organic and Medicinal Chemistry) and the Enzyme and Receptor Inhibitors research theme at the ICCF (Institut de Chimie de Clermont-Ferrand). His work focuses on developing synthetic routes for nitrogenous heterocyclic compounds as potential kinase inhibitors for cancer and neurodegenerative diseases.

Education and Career:

• 2004: Chemical Engineer (École Nationale Supérieure de Chimie de Mulhouse)
• 2004: DEA in Organic and Bioorganic Chemistry (University of Haute Alsace)
• 2007: PhD from University of Nantes (thesis on antifungal/antiparasitic indole derivatives)
• 2008: Postdoc at Rennes (fluorinated melatonin analogs)
• 2009: ATER at Blaise Pascal University (synthesis of anticancer meridianin analogs)
• 2010: Appointed Lecturer at Blaise Pascal University
• 2017: Obtained Habilitation to Supervise Research

Research Themes:

His research emphasizes designing synthetic pathways for bioactive heterocyclic compounds, targeting anticancer and antifungal applications. Key areas include kinase inhibitors, immunosuppressive agents, and anticancer drug development.

Affiliations:

• Member of ICCF (Institut de Chimie de Clermont-Ferrand)
• Member of the Enzyme and Receptor Inhibitors research team